Back to search
Chronic Blepharitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Blepharitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Blepharitis trials you may qualify forBlepharitis is a endemic inflammatory disease caused mainly by Demodex folliculorum and Demodex Brevis, This mites are often associated with anaerobic bacteria…
Objective: To determine the preliminary outcome of external over the counter (OTC) povidone iodine (PI) application in the management of chronic and acute bleph…
This is a Phase IV, single site, randomized, double masked, parallel control clinical trial of 60 subjects to investigate the variance of efficacy between Lotem…
This is a randomized clinical trial to determine the safety and efficacy of terpinen-4-ol (T4O), the most active ingredient of tea tree oil (TTO), in eradicatin…
The primary objective of this study is to demonstrate the efficacy of T1225 eye drops versus placebo eye drops on the global ocular discomfort (VAS).
The purpose of this study is to evaluate the clinical efficacy and safety of Tobradex ST compared to AzaSite in the treatment of moderate to severe chronic blep…
The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs \& symptoms of blepharitis and tear cytokine and e…
The purpose of this study is to determine: * The prevalence of Demodex sp. in chronic blepharitis. * The efficacy of the treatment of topical Tree Tea Oil in c…